Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Clinical Immunology · RAC2-Related Combined Immunodeficiency, Bronchiectasis, and Cancer-Predisposing Syndrome

Protecting Your Health: Managing Infections and Lung Care

At a Glance

RAC2-related immunodeficiency care centers on preventing infections, protecting the lungs with airway clearance when bronchiectasis is present, monitoring sputum and persistent viruses, avoiding unapproved live vaccines, and seeking urgent help for serious warning signs.

For individuals with RAC2-related immunodeficiency, managing health is often a daily practice of protecting the lungs and staying vigilant against infections. Because this condition affects several types of white blood cells, the body can struggle to clear bacteria or control persistent viruses [1][2]. This page provides a roadmap for managing these challenges and helps you recognize when a symptom requires immediate medical attention.

Strengthening Your Defenses

Depending on your individual immune phenotype and infection history, your specialist may consider supporting the immune system to prevent infections.

Immunoglobulin Replacement Therapy (IgRT)

Many people with RAC2 mutations have antibody deficiency, meaning their B cells do not produce enough immunoglobulins (antibodies) [1].

  • How it works: IgRT provides you with antibodies collected from healthy donors [3]. This can be given as an IVIG (intravenous infusion) or SCIG (subcutaneous infusion under the skin) [4].
  • The Goal: There is no universal RAC2 IgG target; the dose and route are individualized based on clinical protection and lab results to prevent serious lung and sinus infections [5].

Preventative Antibiotics

Doctors may consider prophylactic antibiotics—low-dose antibiotics taken daily or weekly [6]. This depends on the immune defect, infection history, and cultures. These keep recurrent infections at bay but carry adverse effects and resistance risks [7][8]. Never start or adjust these medications without your specialist’s instruction.

Vaccine Safety Warning

Because RAC2 causes a combined immunodeficiency, live vaccines (such as MMR, varicella, rotavirus, intranasal flu, or BCG) may be dangerous. Do not receive any live vaccines without direct approval from your immunologist. Non-live vaccines may be safe but might produce a weaker response.

Breathing Better: Managing Bronchiectasis

If frequent infections have led to bronchiectasis—a condition where the airways become permanently widened and scarred—the focus shifts to airway clearance [9]. Scarred airways become “pockets” where mucus gets trapped, allowing bacteria like Pseudomonas aeruginosa to grow [10].

Airway Clearance Techniques (ACT)

Techniques and devices should be selected and taught by a respiratory physiotherapist or pulmonologist.

  • Techniques & Devices: These include manual techniques, oscillating PEP (positive expiratory pressure) devices, or high-frequency chest wall oscillation (HFCWO) vests [9][7].
  • Saline Inhalation: Inhaling hypertonic saline through a nebulizer can help thin the mucus, though it must be monitored as it can provoke bronchospasm [11].

Sputum Monitoring

Regularly culturing your sputum is a vital part of care. By testing the mucus in a lab, doctors can see exactly which bacteria are in your lungs [10]. If Pseudomonas is found, eradication therapy is culture-directed and varies by age, susceptibility, and specialist practice [7][12].

Viral Vigilance

Certain viruses can persist in some RAC2 patients.

  • HPV (Human Papillomavirus): Some mutations can make it very hard to clear warts [2]. Regular skin checks and, for some, gynecologic or anal screenings are evaluated on a risk-adapted basis [13].
  • EBV (Epstein-Barr Virus): This virus can stay active in the body. Doctors may monitor the “viral load” in the blood if lymphoproliferation is suspected [14][15].

Knowing When to Act: The Red Flags

Because your immune system functions differently, your body may not always produce a high fever. You must rely on a clinician-provided action plan. Note that local emergency numbers and transplant-center instructions take precedence over generic thresholds.

Level 1: Emergency Services (Go to ER or Call Emergency Number)

Seek immediate emergency care if you or your child experience:

  • Severe Respiratory Distress: Gasping for air, blue tint to the lips or fingernails (cyanosis), or the skin pulling in around the ribs or neck [16][17].
  • Signs of Sepsis: Confusion, extreme sleepiness, or rapidly worsening symptoms with cold, clammy skin [18].
  • Increasing Hemoptysis: Coughing up increasing or more than minimal amounts of bright red blood [19].
  • Low Oxygen: If you use a pulse oximeter and the number drops significantly below your clinician-provided baseline and does not come up [20].

Level 2: Same-Day Medical Review

Contact your immunology or pulmonology team the same day for:

  • Acute Exacerbation: A sudden “flare” of bronchiectasis marked by a change in cough, mucus, or a new fever [21].
  • Uncontrolled Infection: Any skin infection or wound that is spreading or not responding to “rescue” antibiotics you have at home [2].
  • Inability to Clear Mucus: If you feel “plugged up” and your usual airway clearance techniques are no longer working.
  • Rapidly Changing Lesions: A rapidly changing wart or nonhealing lesion.

Level 3: Discuss at Next Routine Visit

Note these items for your next scheduled appointment:

  • Mild Fatigue: Feeling more tired than usual without a clear cause.
  • Minor Swollen Nodes: Small lumps in the neck, armpits, or groin that are not changing rapidly [14].

Common questions in this guide

What does immunoglobulin replacement therapy do for RAC2-related immunodeficiency?
Immunoglobulin replacement supplies antibodies collected from healthy donors when the body does not make enough of its own. It can be given through a vein as IVIG or under the skin as SCIG, and the dose is adjusted based on infection protection and laboratory results rather than one universal target.
When are preventive antibiotics used in RAC2-related immunodeficiency?
A specialist may prescribe low-dose preventive antibiotics when a person’s immune findings, infection history, or cultures suggest they could reduce recurrent infections. They can cause side effects and contribute to antibiotic resistance, so they should never be started or changed without specialist guidance.
Are live vaccines safe for someone with RAC2-related immunodeficiency?
Live vaccines, including MMR, varicella, rotavirus, intranasal flu, and BCG, may be dangerous with combined immunodeficiency and should not be given without direct immunologist approval. Non-live vaccines may be appropriate, but they may produce a weaker immune response.
What airway-clearance treatment helps RAC2-related bronchiectasis?
A respiratory physiotherapist or pulmonologist can teach airway clearance using manual techniques, oscillating positive expiratory pressure devices, or a high-frequency chest-wall-oscillation vest. Nebulized hypertonic saline may thin mucus for some people, but it can trigger bronchospasm and needs clinician guidance.
Why are sputum cultures important in bronchiectasis?
A sputum culture identifies bacteria growing in the lungs, including Pseudomonas aeruginosa, and helps clinicians choose treatment. If Pseudomonas is present, eradication treatment is tailored to age, the results of antibiotic-sensitivity testing, and specialist practice.
Which symptoms require emergency help in RAC2-related immunodeficiency?
Get emergency help for severe trouble breathing, blue lips or nails, confusion, extreme sleepiness, cold clammy skin with rapidly worsening illness, increasing coughing of bright-red blood, or oxygen levels that stay well below the person’s usual baseline. A clinician-provided action plan and local emergency instructions should take priority.
When should the immunology or lung team be contacted the same day?
Call the care team the same day for a sudden change in cough or mucus, a new fever, mucus that cannot be cleared, a spreading skin infection, a wound not improving with the prescribed rescue plan, or a rapidly changing wart or nonhealing lesion. People with RAC2-related immunodeficiency may not develop a high fever, so changes from the usual baseline matter.

Get notified when new evidence is published on RAC2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Clinical and functional spectrum of RAC2-related immunodeficiency.

    Donkó Á, Sharapova SO, Kabat J, et al.

    Blood 2024; (143(15)):1476-1487 doi:10.1182/blood.2023022098.

    PMID: 38194689
  2. 2

    Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.

    Desjardins A, Marois L, Donkó Á, et al.

    Frontiers in immunology 2026; (17()):1723142 doi:10.3389/fimmu.2026.1723142.

    PMID: 41685306
  3. 3

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  4. 4

    Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.

    Wasserman RL

    Immunology and allergy clinics of North America 2019; (39(1)):95-111 doi:10.1016/j.iac.2018.08.001.

    PMID: 30466775
  5. 5

    Immunoglobulin G Trough Levels and Infection Risk in Adults with Inborn Errors of Immunity Receiving Immunoglobulin Therapy.

    Aktaş ÖÖ, Özer NO, Kaplankıran C, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091549.

    PMID: 41010940
  6. 6

    Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.

    Edgar JDM, Richter AG, Huissoon AP, et al.

    Journal of clinical immunology 2018; (38(2)):204-213 doi:10.1007/s10875-017-0469-4.

    PMID: 29423883
  7. 7

    Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand.

    Chang AB, Bell SC, Byrnes CA, et al.

    Respirology (Carlton, Vic.) 2023; (28(4)):339-349 doi:10.1111/resp.14479.

    PMID: 36863703
  8. 8

    Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.

    Chalmers JD, Boersma W, Lonergan M, et al.

    The Lancet. Respiratory medicine 2019; (7(10)):845-854 doi:10.1016/S2213-2600(19)30191-2.

    PMID: 31405828
  9. 9

    Management of bronchiectasis in adults.

    Visser SK, Bye P, Morgan L

    The Medical journal of Australia 2018; (209(4)):177-183 doi:10.5694/mja17.01195.

    PMID: 30107772
  10. 10

    Hot topics and current controversies in non-cystic fibrosis bronchiectasis.

    Severiche-Bueno D, Gamboa E, Reyes LF, Chotirmall SH

    Breathe (Sheffield, England) 2019; (15(4)):286-295 doi:10.1183/20734735.0261-2019.

    PMID: 31803263
  11. 11

    Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review.

    Annoni S, Bellofiore A, Repossini E, et al.

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2020; (90(1)) doi:10.4081/monaldi.2020.1107.

    PMID: 32072797
  12. 12

    Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.

    Conceição M, Shteinberg M, Goeminne P, et al.

    European respiratory review : an official journal of the European Respiratory Society 2024; (33(171)) doi:10.1183/16000617.0178-2023.

    PMID: 38296344
  13. 13

    Hyper-IgE and Carcinoma in CADINS Disease.

    Pietzsch L, Körholz J, Boschann F, et al.

    Frontiers in immunology 2022; (13()):878989 doi:10.3389/fimmu.2022.878989.

    PMID: 35651609
  14. 14

    Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

    Roberti G, Maestrini G, Polito B, et al.

    Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.

    PMID: 40944054
  15. 15

    Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series.

    Costagliola G, De Marco E, Consonni F, et al.

    Annals of hematology 2025; (104(6)):3117-3127 doi:10.1007/s00277-025-06456-1.

    PMID: 40553169
  16. 16

    High flow nasal cannula for adult acute hypoxemic respiratory failure in the ED setting.

    Long B, Liang SY, Lentz S

    The American journal of emergency medicine 2021; (49()):352-359 doi:10.1016/j.ajem.2021.06.074.

    PMID: 34246166
  17. 17

    [Non-invasive respiratory support for acute respiratory failure with focus on high-flow oxygen therapy and non-invasive Ventilation].

    Fisser C, Malfertheiner M, Lepper PM, Mang S

    Pneumologie (Stuttgart, Germany) 2026; (80(7)):493-499 doi:10.1055/a-2776-7023.

    PMID: 41565209
  18. 18

    Case Report: Human metapneumovirus infection leading to septic shock in an adult with COPD and morbid obesity.

    Virzì F, Giacopelli G, Tutone P, et al.

    Frontiers in medicine 2025; (12()):1735031 doi:10.3389/fmed.2025.1735031.

    PMID: 41488075
  19. 19

    Hemoptysis and the Risk for Lung Transplant or Death without Transplant in Individuals with Cystic Fibrosis in the United States.

    Bayomy OF, Ramos KJ, Hee Wai T, et al.

    Annals of the American Thoracic Society 2022; (19(12)):1986-1992 doi:10.1513/AnnalsATS.202202-110OC.

    PMID: 35759341
  20. 20

    Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before-after study.

    Macé J, Marjanovic N, Faranpour F, et al.

    The American journal of emergency medicine 2019; (37(11)):2091-2096 doi:10.1016/j.ajem.2019.03.004.

    PMID: 30857910
  21. 21

    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.

    Hill AT, Haworth CS, Aliberti S, et al.

    The European respiratory journal 2017; (49(6)) doi:10.1183/13993003.00051-2017.

    PMID: 28596426

This page is for informational purposes only and does not constitute medical advice. Your immunologist and pulmonologist should tailor vaccine decisions, airway-clearance methods, medicines, and emergency instructions to your situation.